U.S pharmaceuticals could benefit from revised U.S-Korea trade pact
U.S. pharmaceuticals may stand to gain if revisions to a longstanding trade agreement between the United States and South Korea, announced in September, are approved and implemented. The updates to the U.S.-Korea Free Trade Agreement (KORUS) include a provision to include American... Read More